Amedica released its first quarter financial results and reported 7 percent increase in silicon nitride ceramic revenue.
Zacks restated the “hold” rating for Bacterin stock.
Bacterin revenue was up 6.6 percent to $9.5 million in the first quarter.
Ceterix Orthopaedics entered into a term loan agreement for up to $35 million in funds.
K2M reported total revenue growth in the first quarter — total reported revenue was up 19.3 percent year-over-year, reaching $50.4 million in the first quarter.
Mazor released its first quarter financial report with recurring quarterly revenue increasing significantly year-over-year.
NuVasive increased revenue in the first quarter of 2015 ahead of launching a new sagittal alignment-focused system.
Plano-based Texas Back Institute performed the first surgery using Safe Orthopaedics’ products in the United States.
St. Jude Medical purchased Spinal Modulation.
Memorial Hermann-The Woodlands (Texas) Hospital incorporated Stryker’s MAKOplasty procedure.
Tornier’s first quarter revenue was $88.1 million, a 1 percent decrease over the same period last year.
The Chinese Firm Xi’an Particle Cloud Advanced Materials Technology is working on a three-dimensional printed artificial bone structure using the Filament Free Printing process.
More articles on devices:
Clinical trials, team growth, IPO — 8 key notes on Bone Therapeutics’ 2014
Implanet Q1 revenue drops 21%, Spine up 77%: 10 key notes
Boston Scientific, Brainlab enter strategic collaboration — 5 key takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
